Law360, New York (September 13, 2006, 12:00 AM ET) -- Pharmaceutical giant Pfizer Inc. has received another victory in its battle to protect Lipitor from generic reproduction, after a Dutch court ruled Ranbaxy Laboratories Ltd.’s version of the cholesterol drug would violate a Pfizer patent.
Pfizer said in a statement Wednesday that the District Court of The Hague in the Netherlands ruled that the basic patent for Lipitor would be infringed by Ranbaxy’s product. A second patent, however, was struck down.
The decision from the court’s three-judge panel prevents India-based Ranbaxy from launching a Dutch version...
Mixed Victory For Pfizer In Dutch Lipitor Battle
To view the full article, take a free trial now.
